Abstract: Leptopsirosis, the world wide zoonosis is considered as re-emerging disease. Besides economic losses caused by Leptopsira to animal production, its zoonotic character makes it an important public health problem Seroepidemiological studies conducted using MAT indicated the dominance of L.hardjo, L.grripotyposa and L. autumnalis in the state. Hence, serovars hardjo, grripotyposa and autumnalis were selected as vaccine candidates for the preparation of trivalent vaccine. The homology and purity of the vaccine candidates were checked using reference antisera procured from ICMR, Port Blair, Center for Diagnosis and typing of leptospira, Andaman and Nicobar Islands and also using hyper immune sera raised against the respective serovars in the present study. The candidate vaccine strains were adopted to low protein medium containing 0.2 percent Bovine serum albumin (BSA) and adjusted the concentration to 2x10 9 cells/ml. The leptospiral organisms were inactivated with 0.5 percent formalin and adjuvanted with aluminum hydroxide (vaccine-I and Montanide (vaccine-II).The vaccines prepared were evaluated for sterility, safety and potency tests. The immune responses were studied in rabbits using both the types of adjuvanted vaccines and could not find any significant differences between the vaccines. The immune response was found to be satisfactory with both the types of vaccines up to 150 days of post vaccinated period tested. The present work has been carried out during 2006 to 2010.
Introduction
Leptospirosis is a wide spread disease [23] caused by a spirochete Leptopsira, which affects almost all mammals [4] . Vaccination is the only reliable means of controlling leptospirosis in all species of animals. Inactivated and attenuated vaccines are especially suitable as veterinary vaccines [24] . The majority of vaccines are formalin inactivated bacterins which contain one or more serotypes [22] , [13] mixed with aluminum hydroxide. Immunity to leptospires is serovar specific [7] . The study was conducted to identify the prevailing serovars in Andhra Pradesh.
A total of 2,320 sera samples representing different districts of the state were subjected to MAT and observed higher prevalence against L. grippotyphosa, L. hardjo and L. autumnalis, the predominant serovars circulating in Andhra Pradesh. L. hardjo was also isolated and are being maintained in the laboratory. The local serovars could not be used in the study for development of vaccine for want of detailed antigenic and genotypic characterization. Hence, the reference strains i.e. grippotyposa, hardjo and autumnalis obtained from reference center ICMR, Port Blair, Andaman and Nicobar Islands were used for preparation of vaccine.
Material and Methods

Selection of Serovars of Leptospira
L. grippotyphosa, L. hardjo and L. autumnalis, the commonly circulating serovars were used for the preparation of vaccine. Leptospira bacterins were prepared as per the production outline of British Pharmacopoeia [5] .
Cultivation of leptospires
Preparation of low protein medium
Low protein medium was prepared accordingly to the protocol followed at Regional medical research center, Port Blair, Andaman and Nicobar islands.
Preparation of charcoal treated tween 80
Charcoal treated (CT) Tween 80 was prepared according to the method described by Bey and Jhonson [3] . Stock solutions of charcoal treated tween 80 were prepared by dissolving 20g of Tween 80 in 200ml of distilled water. While the solution of tween is stirring, 40g of activated charcoal was added gently to ensure homogeneous suspension of charcoal particles. The Tween was then carefully decanted from the charcoal sediment and centrifuged at 10,000 g for 1h and sterilized using 0.22µm filter membrane. The stock solution of charcoal treated tween was stored at 4 O C.
Adaptation of leptospires to low protein medium
EMJH media containing 10 percentages, 7.5 percentage, 5percentage, 2.5 percentage, 1 percentage and 0.2 percentage of BSA were prepared. They were distributed into 4ml of aliquots and checked for sterility by keeping at room temperature for a week. 5 to 7 day old cultures containing 2X10 9 organisms per ml were added to media containing 10percentage BSA and subcultured once in a week for three times. Later leptospiral serovars were further subcultured serially in media containing 7.5 percentages, 5 
Preparation of leptospira suspension
The three serovars namely L.autumnalis, L.gripptotyphosa, and L.hardjo selected for preparation of vaccine were grown separately in cell culture bottles containing 18ml of the low protein medium. Two ml of leptospiral seed stock cultures were inoculated and incubated at 29 O C ± 1 O C for 10 to 12 days. Cultures containing more than 2X10 9 organisms per ml were used as inoculum for further cultivation of organisms in bulk for preparation of vaccine.
Twenty ml of inoculum thus prepared containing L.autumnalis, L.gripptotyphosa and L.hardjo was inoculated in each of the three bottles containing 180ml of low protein medium. The cultures were incubated at 29 O C± 1 O C for 10 to 12 days. The concentration of leptospires was adjusted to 2X10 9 leptospires per ml of each serovar for preparation of vaccine.
Before inactivation of the organisms the purity of the organisms were checked using dark field microscopy. If suspected for minor contamination the leptospiral organisms were passed through 0.22µm filters for clarity. Further, the cultures were also checked for sterility using blood agar medium, Saubourads dextrose agar medium and Thioglycollate medium in duplicates.
Preparation of Vaccines
The cultures thus obtained were inactivated with 0.5% formalin and adjuvanted with two types of adjuvants namely aluminium hydroxide and Montanide ISA 206 separately.
Formalin inactivation
The cultures thus obtained were inactivated by adding 1ml of formalin (0.5percentage) to each bottle containing 200ml of leptospiral suspension. Later cultures were tested for success of inactivation. Inactivated cultures along with fresh leptospira cultures of L.autumnalis, L.gripptotyphosa, and L.hardjo were inoculated into 4.5ml of fresh EMJH liquid media, incubated for 14 days at 29 O C± 1 O C and examined the growth of leptospira under dark field microscope.
After confirming the successful inactivation the cultures were incubated at 37 O C under stirring. The cultures were harvested by centrifugation at 14,000 g at 4 0 C. The sediment was resuspended in PBS and washed thrice with PBS. Then the formalized leptospries were resuspended in PBS to a concentration of 2X10 9 organisms per ml. All the bacterins thus prepared were mixed in equal quantities together and bacterin suspension was aliquoted equally in two separate bottles.
Aluminium hydroxide
The bottle containing the bacterins were subjected to centrifugation and separated the pellet. The pellet was mixed with 20ml of aluminum hydroxide gel thoroughly and made upto 100ml using PBS. The vaccine produced was distributed in 2ml glass bottles labeled as Vaccine I and stored in refrigeration.
Montanide ISA 206
Similarly another bottle containing bacterins was also subjected to centrifugation and pellet was mixed with 46.2ml of Montanide ISA 206 and homogenized thoroughly. Later the volume was made up to 100ml with PBS. The vaccine was distributed into 2ml glass bottles, labelled and stored in refrigerator for future use as Vaccine II.
Standardization of the Vaccine
Standardization of the vaccines was done according to the British pharmacopoeia [5] . The organisms were adopted to grow from high protein to low protein (up to 0.2 percent) concentration of BSA. In the process of adaptation, growth of leptospires in low protein medium containing 0.2 percent BSA, the organisms were found to grow at a concentration of 2 x 10 9 organisms per ml by 10 th to 12 th day of inoculation. The details of growth of leptospires are shown in Table. organisms/ml were inactivated using 0.5 ml of formalin for 24 hrs.
Results
Serovars namely
Standardization of Vaccine
Vaccine was prepared with inactivated leptospira using aluminium hydroxide (vaccine-I) and mountanide (vaccine-II) as adjuvants. The adjuvanted vaccines, Vaccine-I (aluminium hydroxide) and Vaccine II (Mountanide) were tested for sterility, safety and potency.
Sterility Test
Blood agar, nutrient agar, sabroaud's agar and thioglycolate medium inoculated with vaccine-I and vaccine-II did not showed any growth of microorganisms and fungi during incubation of 14 days at 30 0 C and 37 0 C regularly.
Safety Test
All the four guinea pigs inoculated with the vaccine preprations did not show any local and systematic reaction and no elevated temperature up to 20 days, the period of observation. No gross lesions were observed in any of the organs in the guinea pigs sacrificed on 20 th day of inoculation. Examination of the liver and kidney tissue impression smears using ADMAS modified silver staining method did not reveal any leptospires.
Potency Test
The vaccinated guinea pigs with vaccine-I and vaccine-II challenged with virulent leptospires of autumnalis, hardjo and grippotyphosa did not show any clinical signs of leptospirosis where as un vaccinated animals die between 7-10 days after challenging with serovars grippotyposa and autumnalis. However, the guinea pigs challenged with hardjo did not die. The weekly mean body temperature s of the guinea pigs is presented in a The un-vaccinated control animals died within 7-10 days in case of autumnalis and grippotyposa but death was not observed in animals challenged with hardjo and further it induced antibody titer of 4.87.
Immune Response in Rabbits
The antibody response in vaccinated rabbits was studied by using MAT and results are shown in table.4. In the present study vaccine strains were adopted to low protein medium containing 0.2% BSA to minimize the adverse reactions such as pyrogenecity and dermal toxicity caused by serum albumin [3] . Adaptation of leptospires to low protein media did not alter the immunogenicity [1] . Activated charcoal powder was used to reduce the toxicity of tween [3] Formalin at the concentration of 0.5 percent was used for inactivation of leptospiral organisms for the preparation of vaccine in the study. Earlier several workers were also used formalin as an inactivating agent in the preparation of leptospiral vaccine [15] , [22] , [13] , [12] and [16] . Further, it was also reported that formalin treated antigen induces strong antibody response [18] and [14] .
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The vaccines thus prepared were evaluated for sterility, safety and potency tests. Under safety test, no raising temperature, local & systemic reactions are seen in inoculated Guinea pigs and it is due to the usage of low protein medium for cultivation of vaccine strains. [8] was also used low protein medium for the growth of leptospiral while preparing the vaccine and obtained similar results.
Sterility of vaccine I (Alum), Vaccine II (Montenied) were checked using nutrient agar, blood agar, thioglycolate media and sabourauds dextrose agar media. Both the vaccines were found to be free from viable bacteria and fungi during incubation of 14 days at 30 o C and 37 o C respectively maximum period tested, meeting the requirements [5] and [9] .
Potency of the vaccine is tested in guinea pigs by measure in antibody titers [16] . In the present study, the guinea pigs vaccinated with vaccine-I and vaccine-II were challenged after 14 days of post vaccination with virulent leptospires of L. autumnalis, L. hardjo and L. grippotyposa did not shown any clinical signs of leptospirosis indicating 100 percent protection. But, un vaccinated animals were died between 7 to 10 days after challenge with serovars L. grippotyposa and l. autumnalis, where as the guinea pigs challenged with .L. hardjo did not die and instead induces antibody titer of 4.81 (GMT log 2 titers). This is in agreement with earlier report of [6] . Some strains may be virulent in some hosts but not in the experimental models. L.noguchii isolated from clinically suffering sheep fails to cause the disease in hamsters [21] .
In vaccinated guinea pigs 14 days after vaccination antibody titer was measured using MAT. Immune responses against two types of adjuvanted vaccines namely vaccine-I (aluminum hydroxide) and vaccine-II (mountanide adjuvanted) were studied in rabbits for a period of 150 days. Both the vaccines induced detectable level of antibodies against all the three serovars incorporated in the vaccine on day 7 th of post vaccination. The GMT log2 MAT titer values followed by vaccine-II was slightly higher than vaccine-I which is significant. The antibody response on the day 30 th to 90 th day was high against all the three serovars in both the vaccines and slight decrease in the antibody titer on the 20 th to 150 th day of immunization (table.5 & fig.4 ). No statistical significant difference was observed in immune responses elicited by both the types of adjuvanted vaccines in rabbits. The antibody response was observed up to 150 days of post vaccination, the maximum period of study.
